Streetbeat News

Price Targets

RRC

In the last 3 months, 19 analysts have offered 12-month price targets for Range Resources (NYSE:RRC), with an average price target of $31.26, a high of $40.00, and a low of $20.00. The average price target has increased by 4.51% over the past month.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 2:09 pm

FL

Deutsche Bank analyst Gabriella Carbone maintains a Hold rating on Foot Locker (NYSE:FL) and lowers the price target from $42 to $28.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:08 pm

GOOGL

A whale has taken a bearish stance on Alphabet (NASDAQ:GOOGL), with 64% of detected unusual options trades being bearish. Whales have been targeting a price range of $90 to $130 for Alphabet over the last 3 months. The stock is currently up 2.31% at $125.6, with RSI indicators suggesting it may be overbought.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 2:08 pm

DE

Deutsche Bank analyst Nicole Deblase maintains a Hold rating on Deere (NYSE:DE) and lowers the price target from $440 to $392.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:02 pm

KRO

Deutsche Bank analyst David Begleiter maintains a Buy rating on Kronos Worldwide (NYSE:KRO) but lowers the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 2:00 pm

SYM

Deutsche Bank analyst Nicole Deblase maintains a Buy rating on Symbotic (NASDAQ:SYM) and raises the price target from $31 to $36.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 1:59 pm

WLKP

Deutsche Bank analyst David Begleiter maintains a Buy rating on Westlake Chemical (NYSE:WLKP) but lowers the price target from $28 to $27.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 1:58 pm

CTLT

Deutsche Bank analyst Justin Bowers maintains a Hold rating on Catalent (NYSE:CTLT) and raises the price target from $29 to $37.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 1:57 pm

TRS

BWS Financial analyst Hamed Khorsand initiates coverage on TriMas (NASDAQ:TRS) with a Buy rating and announces a price target of $40.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 1:47 pm

AVNS

CL King analyst Kristen Stewart initiates coverage on Avanos Medical (NYSE:AVNS) with a Buy rating and announces a price target of $31.

Portfolio Pulse from richadhand@benzinga.com

May 22, 2023 | 1:45 pm